Resident of the world, traveling the road of life
5004 stories
·
9 followers

American Sniper schießt auf NSA-Gebäude

1 Share

k

Nachrichten aus Kultur und Medien

In Baltimore-Washington und Fort Meade hat es am Dienstag zwei Angriffe mit Schusswaffeneinsatz gegeben, wobei in einem Fall ein Gebäude der NSA getroffen wurde. Stunden zuvor war 12 Meilen entfernt auf einen fahrenden LKW geschossen worden. In beiden Fällen kamen keine Personen zu Schaden. Möglicherweise ist der unbekannte Täter auch für weitere ungeklärte Schüsse verantwortlich.

Nachrichtenwert hat die Meldung nur aufgrund des getroffenen NSA-Gebäudes. In den USA ist es Brauch, auf Sachen und Menschen zu schießen. Jährlich gibt es in den USA über eine Million Schussverletzungen, davon 30.000 tödliche. Diese Form der Auseinandersetzung wird in den Vereinigten Staaten traditionell nicht als Terrorismus empfunden und gehört insbesondere nicht zum Aufgabengebiet der Geheimdienste CIA und NSA, die für die weltweit unter 100 jährlichen US-Terrorismusopfer zuständig sind und mit dieser Begründung den Planeten überwachen.

Trotz der hohen Intelligence sehen die US-Sicherheitsbehörden keinen Zusammenhang zwischen dem praktisch unkontrollierten Waffenbesitz und der grotesk hohen Opferzahl. Die unterirdischen NSA-Spione im Dagger-Complex bei Griesheim rätseln vermutlich noch immer, warum in Deutschland jährlich lediglich 70 Menschen unfreiwillig erschossen werden.

2002 brachten es die American Sniper John Allen Muhammad und Lee Boyd Malvo zu weltweiter Aufmerksamkeit, die in der gleichen Gegend willkürlich mindestens zehn Menschen erschossen. Muhammad hatte seine Schießkünste in der US Army gelernt und im Golfkrieg gedient. Derzeit läuft in den USA mit großem Erfolg der Kinofilm 'American Sniper' über den Scharfschützen Chris Kyle, der ebenfalls im Irak aus dem Hinterhalt mindestens 160 Menschen erschoss, bis ihn ein traumatisierter Golfkriegsveteran mit einer Schusswaffe im eigenen Land niederstreckte. Während Sarah Palin den Film als 'pariotisches Meisterwerk' rühmt, fragte Noam Chomsky, was die Verehrung eines kaltblütigen Killers mittels eines Kinofilms über das amerikanische Volk aussage.

Read the whole story
Share this story
Delete

Today, we’re celebrating the 168th birthday of Thomas...

1 Share


Today, we’re celebrating the 168th birthday of Thomas Edison with a little inspiration from the man himself. 

"Just because something doesn’t do what you planned it to do doesn’t mean it’s useless." - Thomas Edison. GIF by Kevin Weir / flux machine

Read the whole story
Share this story
Delete

Die US-Atomwaffen bleiben in Deutschland.Wartet, wartet, ...

2 Shares
Die US-Atomwaffen bleiben in Deutschland.

Wartet, wartet, das ist noch nicht die Pointe. Das hier ist die Pointe:

Die internationalen Bemühungen um Abrüstung, auch im nuklearen Bereich, würden jedoch durch den Ukraine-Konflikt erheblich belastet.
Wegen der Ukraine-Situation! Da muss man sich die Option offenhalten, mal ne ordentliche amerikanische Atombombe abzuwerfen!1!!
Read the whole story
Share this story
Delete

Google seems to have broken email forwarding

jwz
1 Share
Basically: I'm finding it impossible to reliably convince Google that email from my employees, to my employees, is not spam.

I run my own mail server, but most of my employees use Gmail. So I have forwarding set up: employee@dnalounge.com simply forwards to employee@gmail.com. When sending mail using their Gmail account, they set their From line to employee@dnalounge.com. (Google lets you do this if you jump through some hoops to verify that you can actually receive mail at that account.)

So when one of them mails another, the mail goes from their phone up to Google's SMTP server, with "From: A@dnalounge.com, To: B@dnalounge.com". That hits the dnalounge.com MX (my machine) and is forwarded back to "B@gmail.com" -- where it then ends up in B's spam folder, because Google (maybe?) thinks it's a "forgery".

I have proper DMARC and DKIM records ("dig TXT mail._domainkey.dnalounge.com; dig TXT _domainkey.dnalounge.com"). TLS is configured properly. I have SPF set to "v=spf1 a mx ptr ~all" (since I do, in fact, want my employees to be able to originate their mail on their ISP's servers.)

What do I have to do to make Google stop fucking me?

Allowing Google to host the dnalounge.com domain is not an acceptable answer. Not having "@dnalounge.com" in the From and To fields is not an acceptable answer.

Forcing all of my employees to use my own IMAP server instead of Gmail would be a moderately terrible answer.


Previously, previously, previously, previously.

Read the whole story
Share this story
Delete

FDA Warns: If Your “Low T” Is Just From Getting Older, Don’t Use Prescription Testosterone

1 Share

In recent years, makers of prescription testosterone treatments like AndroGel began throwing around the term “Low T” in TV ads, blaming low levels of the hormone for various problems — sex drive, flagging energy, moodiness — that have long been associated with simply growing older. But the FDA is now acknowledging that these drugs pose “a possible increased risk of heart attack and stroke” and are warning against their use for the treatment of anything other than very specific medical conditions.

Prescription testosterone is only FDA-approved for men with low testosterone levels due to disorders of the testicles, pituitary gland, or brain that cause a condition called hypogonadism.

But in an announcement made Tuesday afternoon, FDA notes that “testosterone is being used extensively in attempts to relieve symptoms in men who have low testosterone for no apparent reason other than aging.”

Citing the possible increased cardiovascular risk, FDA is requiring labeling changes for all prescription testosterone products to “reflect the possible increased risk of heart attacks and strokes associated with testosterone use.”

The agency is asking doctors and other health care professionals to alert patients of the risks associated with testosterone. Patients using testosterone should seek medical attention immediately if symptoms of a heart attack or stroke are present, such as: chest pain, shortness of breath or trouble breathing, weakness in one part or one side of the body, or slurred speech.

“We are also requiring manufacturers of approved testosterone products to conduct a well-designed clinical trial to more clearly address the question of whether an increased risk of heart attack or stroke exists among users of these products,” reads the announcement.

The FDA first announced that it was investigating the potential cardiovascular risks of these gels in Jan. 2014 after two studies raised safety questions.

The first study, published in 2013 in the Journal of American Medical Association, looked at a group of men (average age: 60) with low serum testosterone. The results of the research indicated that men undergoing testosterone treatment may be at a 30% increased risk of stroke, heart attack, and death.

A second study observed an increased risk of heart attack in both older men and in younger men with pre-existing heart disease, who filled a prescription for testosterone therapy. For men over the age of 65 who were being treated with testosterone, researchers claimed a twofold increase in the risk of heart attack in the first 90 days after beginning treatment. For younger men with a pre-existing history of heart disease, the study found a two- to threefold increased risk of heart attack in the first 90 days. The study did not see any increased risk for heart attack in younger men.

In Feb. 2014, health safety advocates at Public Citizen petitioned the FDA for a “black box” warning on testosterone packaging about cardiovascular risks, or at least a patient medication guide. In June 2014, FDA rejected the petition, claiming “insufficient evidence.”

Around the same time, regulators in Canada concluded that studies on testosterone treatments “provide evidence in support of this possible association when considered as a whole.”

“In the seven and a half months since the Canadian action, approximately four million [testosterone] prescriptions have been filled in the U.S.,” reads a statement from Public Citizen. “Had the FDA made this announcement last summer when the Canadian government acted, it would have reduced the number of U.S. prescriptions for and damage from testosterone, a medication of questionable effectiveness for a large proportion of users and one that increases the risk of heart attacks and strokes.”

Read the whole story
Share this story
Delete

Tesla Asks Drivers To Please Stop Souping Up Their Cars

1 Share

Sometimes the factory radio just doesn’t cut it in your new vehicle. While swapping out the sound system, and other features – rims, seat covers, tires – is an established way for consumers to put their personal stamp on cars, one automaker is asking them not to, because, you know, it could pose a safety risk, which isn’t good for business.

Business Insider reports that Tesla’s 2014 annual report featured an interesting twist on the risks facing the company: the personalization of the Model S.

While it is reasonable to think that consumers customizing an electric car’s charging infrastructure  and wiring could very well affect the way the car operates, things like raised seats and new tires don’t exactly sound devastating to the company – or unsafe for customers.

But according to Tesla’s filing they can be.

“We are aware of customers who have customized their vehicles with after-market parts that may compromise driver safety,” the company reports. “For example, some customers have installed seats that elevate the driver such that airbag and other safety systems could be compromised. Other customers have changed wheels and tires, while others have installed large speaker systems that may impact the electrical systems of the vehicle. We have not tested, nor do we endorse, such changes or products.”

The company goes on to say that modifications could reduce the safety of vehicles, and that any adverse publicity from such events would “negatively affect our brand and harm our business, prospects, financial condition and operating results.”

Tesla to owners: Please don’t pimp your rides [Business Insider]

Read the whole story
Share this story
Delete
Next Page of Stories